Invention Grant
- Patent Title: Cysteine protease inhibitors for the treatment of parasitic diseases
- Patent Title (中): 半胱氨酸蛋白酶抑制剂治疗寄生虫病
-
Application No.: US13861046Application Date: 2013-04-11
-
Publication No.: US08642799B2Publication Date: 2014-02-04
- Inventor: Elise Isabel , Christopher Mellon , Christian Beaulieu
- Applicant: Elise Isabel , Christopher Mellon , Christian Beaulieu
- Applicant Address: CA Quebec
- Assignee: Merck Canada Inc.
- Current Assignee: Merck Canada Inc.
- Current Assignee Address: CA Quebec
- Agent Alysia A. Finnegan; Sheldon O. Heber
- Main IPC: C07C255/04
- IPC: C07C255/04 ; A61K31/275

Abstract:
Several parasites responsible for mammalian diseases are dependent on cysteine protease for various life-cycle functions. Inhibition or decreasing function of these proteases can be useful in the treatment and/or prevention of these parasitic diseases including; toxoplasmosis, malaria, African trypanosomiasis, Chagas disease, leishmaniasis, schistosomiasis, amebiasis, giardiasis, clonorchiasis, opisthorchiasis, paragonimiasis, fasciolopsiasis, lymphatic filariasis, onchocerciasis, dracunculiasis, ascariasis, trichuriasis, stronglyoidiasis, trichostrongyliasis, trichomoniasis or cestodiasis.
Public/Granted literature
- US20130244962A1 CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES Public/Granted day:2013-09-19
Information query